A higher proportion of patients with ADA-positive status at follow-up did not achieve the status of B cell depletion (CD19% in peripheral blood < 0.5%), although this did not reach statistical significance (Fig. 2 d-f).
← all excerpts
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis.
1
—
—